Reduction of plasma apolipoprotein-B by effective removal of circulating glycation derivatives in uremia

Kidney International

Volumn 52, Issue 6, 1997, Pages 1645-1650

  Fishbane, Stephen ^b   Bucala, Richard ^b   Pereira, Brian J G ^b   Founds, Hank ^b   Vlassara, Helen ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b NONE

Author keywords

Advanced glycation endproducts (AGEs); Apolipoprotein B (ApoB); Dyslipidemia diabetic ESRD; Low density lipoprotein (LDL); Uremia

Indexed keywords

APOLIPOPROTEIN B; GLYCOSYLATED PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSIS MEMBRANE; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; MALE; MEMBRANE FILTER; PRIORITY JOURNAL; UREMIA;

EID: 0031463893     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.497     Document Type: Article

References (28)

1. U.S. RENAL DATA SYSTEM:, USRDS 1995 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, Maryland, April 1995
2. KANNEL WB, CASTELLI WP, GORDON J: Cholesterol in the prediction of atherosclerotic disease. New perspectives on the Framingham study. Ann Intern Med 90:85-91, 1979
3. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WITZTUM JL: Beyond cholesterol. Modifications of low-density lipoportein that increase its atherogenicity. Comment in N Engl J Med 321:1196-1197, 1989
4. ROSS R: The pathogenesis of atherosclerosis, an update. N Engl J Med 8:488-500, 1986
5. BUCALA R, MAKITA Z, VEGA G, GRUNDY S, KOSCHINSKY T, CERAMI A, VLASSARA H: Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 91:9441-9445, 1994
6. BUCALA R, MAKITA Z, KOSCHINSKY T, CERAMI A, VLASSARA H: Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438, 1993
7. BRADLEY WA, GOTTO AM JR: Structure of intact human lipoproteins, in Disturbances in Lipid and Lipoprotein Metabolism, edited by DIETSCHY JM, GOTTO AM JR, ONTKA TA, New York. American Physiological Society, 1978, p 111
8. KNOTT TJ, PEASE RJ, POWELL LM, WALLIS SC, RALL SC JR. INNERARITY TL: Complete protein sequence and identification of structural domains of human apoprotein B. Nature 323:734-738, 1996
9. BROWN MS, GOLDSTEIN JL: A receptor mediated pathway for cholesterol homeostasis. Science 232:34-47, 1986
10. MAKITA Z, RADOFF S, RAYFIELD EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA, CERAMI A, VLASSARA H: Advanced glycosylated end-products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
11. BROWNLEE M, CERAMI A, VLASSARA H: Advanced glycosylated end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-132, 1988
12. VLASSARA H, BUCALA R, STRIKER L: Pathogenic effects of advanced glycosylation; biochemical, biologica, and clinical implications for diabetes and aging. J Lab Invest 70:138-151, 1994
13. VLASSARA H: Protein glycation in the kidney: Role in diabetes and aging. Kidney Int 49:1795-1804, 1996
14. BROWN MS, GOLDSTEIN JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52:223-261, 1983
15. MAKITA Z, BUCALA R, RAYFIELD EJ, FRIEDMAN EA, KAUFMAN AM, KORBET SM, BARTH RH, WINSTON JA, FUH H, MANOGUE KR, CERAMI A, VLASSARA H: Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet 343:1519-1522, 1994
16. DUMLER F, STALLA K, MOHINI R, ZASUWA G, LEVIN NW: Clinical experience with short time hemodialysis. Am J Kidney Dis 19:49-56, 1992
17. MAKITA Z, VLASSARA H, CERAMI A, BUCALA R: Immunochemical detection of advanced glycosylation endproducts in vivo. J Biol Chem 267:5133-5138, 1992
18. CONTOIS JH, MCNAMARA JR, LAMMI-KEEFE CJ, WILSON PWF, MASSOV T, SCHAFFER EJ: Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: Results from the Framingham Offspring Study. Clin Chem 42:515-523, 1996
19. MAGGI E, BELLAZZI R, FALASCHI F, FRATTONI A, PERANI G, FINARDI G, GAZO A, NAI M, ROMANINI D, BELLOMO G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 45:876-883, 1994
20. READE V, TAILLEUX A, READE R, HARDUIN P, CACHERA C, TACQUET A, FRUCHART JC, FIEVET C: Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients. Kidney Int 44:1360-1365, 1993
21. BUCALA R, MITCHELL R, ARNOLD K, INNERARITY T, VLASSARA H, CERAMI A: Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J Biol Chem 270:10828-10832, 1995
22. VLASSARA H, FUH H, MAKITA Z, LKRUNGKRAI S, CERAMI A, BUCALA R: Exogenous advanced glycosylation endproducts induce comples vascular dysfunction in normal animals: A model for diabetic and aging complications. Proc Natl Acad Sci USA 90:6434-6438, 1992
23. VLASSARA H, FUH H, DONNELLY T, CYBULSKY M: Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Molec Med 1:447-456, 1995
24. PAPANASTASIOU P, GRASS L, RODELA H, PATRIKAREA A, OREOPOULOS D, DIAMANDIS EP: Immunological quantication of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222, 1994
25. EKNOYAN G, LEVEY AS, BECK GJ, AGODOA LY, DAUGIRDAS JT, KUSEK JW, LEVIN NW, SCHULMAN G: The hemodialysis (HEMO) study: Rationale for selection of intervetions. Semin Dial 9:24-33, 1996
26. JOSEPHSON MA, FELLNER SK, DASGUPTA A: Improved lipid profiles in patients undergoing high-flux hemodialysis. Am J Kidney Dis 20:361-366, 1992
27. SERES DS, STRAIN GW, HASHIM SA, GOLDBERG IJ, LEVIN NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3:1409-1415, 1993
28. BLANKESTIJN PJ, VOS PF, RABELINK TJ, VAN RIJN HJM, JANSEN H, KOOMANS HA: High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J Am Soc Nephrol 5:1703-1708, 1995